Basic Search
|
Geographic Searches
|
Advanced Search |
MegadealsSubsidy Tracker: Industry Summary Page
Major Industry: pharmaceuticals
Subsidy Total: $3,972,211,621
Number of Awards: 2,783
Time Period: Earliest year of data: 1975. Availability of data for earlier years varies greatly from program to program. The majority of the listings for this industry are for the period since 2012.
Notes: The dollar total above adjusts for the fact that there is an overlap between the amounts in one or more Megadeal entries and those of one or more of the other entries. The total includes only those entries matched to a parent company. The industry designation is the primary one for the parent's operations overall. Dollar totals do not include awards for which no subsidy value is disclosed.
Top 10 Parent Companies | Total Subsidy $ | Number of Awards |
Eli Lilly | $601,741,368 | 77 |
Regeneron Pharmaceuticals | $469,433,071 | 112 |
AstraZeneca | $436,175,713 | 52 |
Pfizer | $332,313,011 | 206 |
Novo Holdings A/S | $241,475,902 | 102 |
Elanco Animal Health | $189,545,200 | 7 |
Merck | $153,889,367 | 82 |
AbbVie | $145,729,008 | 68 |
Johnson & Johnson | $111,279,431 | 124 |
Bristol-Myers Squibb | $110,616,473 | 81 |
Individual Subsidy Records:
Warning: Attempt to read property "post_title" on string in
/usr/home/goodjobsfirst/public_html/subsidytrackerlive/function.php on line
2057
Warning: Attempt to read property "post_name" on string in
/usr/home/goodjobsfirst/public_html/subsidytrackerlive/function.php on line
2059
Company | Parent | Location | Subsidy Source | Year | Subsidy Value | Loan/Bailout Value | Type of Subsidy |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,524 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,524 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,524 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,524 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,550 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,550 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,550 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $8,550 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,675 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,675 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,675 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $10,675 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $11,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $11,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $11,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $11,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $15,400 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $15,400 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $15,400 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $15,400 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $19,463 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $19,463 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $19,463 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $19,463 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $20,000 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $32,600 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $32,600 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $32,600 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $32,600 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $7,800 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $7,293 | | cost reimbursement |
Pharmavite LLC | Otsuka Pharmaceutical | Alabama | state | 2013 | $7,200 | | cost reimbursement |
CSL Plasma, Inc. | CSL Limited | Arizona | state | 2010 | undisclosed | | enterprise zone |
CSL Plasma, Inc. | CSL Limited | Arizona | state | 2010 | undisclosed | | enterprise zone |
Ventana Medical Systems | Roche | Arizona | state | 2003 | $585,765 | | training reimbursement |
Abbott Laboratories, Ross Products Div | Abbott Laboratories | Arizona | state | 2004 | $235,647 | | training reimbursement |
Ventana Medical Systems, Inc. | Roche | Arizona | state | 2005 | $443,248 | | training reimbursement |
Ventana Medical Systems, Inc. | Roche | Arizona | state | 2007 | $129,073 | | training reimbursement |
Ventana Medical Systems, Inc. | Roche | Arizona | state | 2007 | $454,796 | | training reimbursement |
Abraxis BioScience, Inc. | Bristol-Myers Squibb | Arizona | state | 2009 | $279,390 | | training reimbursement |
Abbott Laboratories | Abbott Laboratories | Arizona | state | 2016 | $240,000 | | training reimbursement |
Versum Materials, Inc. | Merck KGaA (EMD) | Arizona | state | 2017 | $2,100,000 | | tax credit/rebate |
Abbott Laboratories | Abbott Laboratories | Arizona | state | 2018 | $1,820,000 | | tax credit/rebate |
Bristol Myers Squibb Company | Bristol-Myers Squibb | Arizona | state | 2022 | $3,000,000 | | tax credit/rebate |
BIOSENSE WEBSTER, INC. | Johnson & Johnson | California | state | 2003 | $78,520 | | training reimbursement |
WATSON LABORATORIES, INC. | Teva Pharmaceutical Industries | California | state | 2003 | $166,452 | | training reimbursement |
NEUTROGENA CORPORATION | Johnson & Johnson | California | state | 2003 | $202,588 | | training reimbursement |
WATSON PHARMACEUTICALS, INC. | Teva Pharmaceutical Industries | California | state | 2005 | $32,240 | | training reimbursement |
DEY, L.P. | Viatris | California | state | 2005 | $121,613 | | training reimbursement |
IDEXX LABORATORIES, INC. | IDEXX Laboratories | California | state | 2006 | $36,530 | | training reimbursement |
VISX INCORPORATED | Abbott Laboratories | California | state | 2006 | $59,748 | | training reimbursement |
HOSPIRA, INC. | Pfizer | California | state | 2006 | $439,595 | | training reimbursement |
ABBOTT DIABETES CARE | Abbott Laboratories | California | state | 2007 | $359,454 | | training reimbursement |
GENENTECH, INC. | Roche | California | state | 2007 | $602,758 | | training reimbursement |
MILLIPORE, INC. | Merck KGaA (EMD) | California | state | 2009 | $1,440 | | training reimbursement |
MILLIPORE, INC. | Merck KGaA (EMD) | California | state | 2009 | $143,620 | | training reimbursement |
HOSPIRA, INC. | Pfizer | California | state | 2009 | $536,590 | | training reimbursement |
ABBOTT DIABETES CARE | Abbott Laboratories | California | state | 2010 | $843,336 | | training reimbursement |
ABBOTT VASCULAR, INC. | Abbott Laboratories | California | state | 2010 | $1,470,600 | | training reimbursement |
VISX, Inc | Abbott Laboratories | California | state | 2004 | undisclosed | | training reimbursement |
Hospira, Inc | Pfizer | California | state | 2007 | undisclosed | | training reimbursement |
Millipore, Inc. | Merck KGaA (EMD) | California | state | 2007 | undisclosed | | training reimbursement |
Millipore Corporation | Merck KGaA (EMD) | California | state | 2009 | undisclosed | | training reimbursement |
MILLIPORE CORPORATION | Merck KGaA (EMD) | California | state | 2011 | $59,646 | | training reimbursement |
GILEAD SCIENCES, INC. | Gilead Sciences | California | state | 2011 | $190,995 | | training reimbursement |
IMPAX LABORATORIES, INC. | Amneal Pharmaceuticals | California | state | 2011 | $195,440 | | training reimbursement |
PHARMAVITE LLC | Otsuka Pharmaceutical | California | state | 2011 | $209,316 | | training reimbursement |
ABBOTT VASCULAR, INC. | Abbott Laboratories | California | state | 2012 | undisclosed | | training reimbursement |
AMYRIS, INC. | Amyris | California | state | 2012 | $99,927 | | training reimbursement |
ABBOTT VASCULAR, INC. | Abbott Laboratories | California | state | 2012 | $249,570 | | training reimbursement |
C3I, INC | Merck | California | local | 2012 | undisclosed | | tax credit/rebate |
KITE PHARMA INC | Gilead Sciences | California | local | 2012 | undisclosed | | tax credit/rebate |
MEDICIS THE DERMATOLOGY CO | Bausch Health | California | local | 2012 | undisclosed | | tax credit/rebate |
ABBOTT MEDICAL OPTICS INC. | Abbott Laboratories | California | state | 2013 | $73,582 | | training reimbursement |
Ultragenyx Pharmaceutical, Inc. | Ultragenyx Pharmaceutical | California | state | 2014 | $2,100,000 | | tax credit/rebate |
Novartis Pharmaceuticals Corp. | Novartis | California | state | 2014 | $1,000,000 | | tax credit/rebate |
Kite Pharma, Inc. | Gilead Sciences | California | state | 2015 | $1,800,000 | | tax credit/rebate |
PHARMAVITE LLC | Otsuka Pharmaceutical | California | state | 2014 | $17,618 | | training reimbursement |
BOEHRINGER INGELHEIM FREMONT, INC. | Boehringer Ingelheim | California | state | 2014 | $248,794 | | training reimbursement |
ABBOTT VASCULAR, INC. | Abbott Laboratories | California | state | 2014 | $344,534 | | training reimbursement |
ALLERGAN INC | AbbVie | California | state | 2015 | $325,700 | | training reimbursement |
AMGEN INC | Amgen | California | state | 2015 | $198,301 | | training reimbursement |
GILEAD SCIENCES INC | Gilead Sciences | California | state | 2015 | $191,250 | | training reimbursement |
Kite Pharma, Inc. | Gilead Sciences | California | state | 2016 | $7,000,000 | | tax credit/rebate |
Abbott Vascular Inc | Abbott Laboratories | California | state | 2016 | $1,201,228 | | training reimbursement |
EMD Millipore Corporation | Merck KGaA (EMD) | California | state | 2018 | $945,000 | | tax credit/rebate |
SAFC Carlsbad, Inc. | Merck KGaA (EMD) | California | state | 2019 | $4,000,000 | | tax credit/rebate |
Exelixis, Inc. | Exelixis | California | state | 2019 | $3,000,000 | | tax credit/rebate |
BOEHRINGER INGELHEIM FREMONT INC | Boehringer Ingelheim | California | state | 2017 | $249,388 | | training reimbursement |
AMGEN INC | Amgen | California | state | 2018 | $198,000 | | training reimbursement |